Screener
Taysha Gene Therapies, Inc. TSHA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-207666
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Restricted cash | 2,315 | 2,315 |
| Property, plant and equipment, net | 6,450 | 6,736 |
| Operating lease right-of-use assets | 9,155 | 9,439 |
| Other non-current assets | 181 | 183 |
| Total assets | $300,351 | $343,320 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $4,564 | $6,275 |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s other non-current assets?
- Taysha Gene Therapies, Inc. (TSHA) reported other non-current assets of $181K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other non-current assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s other non-current assets decreased by 3.7% year-over-year, from $188K to $181K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other non-current assets?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s other non-current assets has grown at a -36.2% compound annual growth rate (CAGR), from $1.11M to $183K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Taysha Gene Therapies, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude